benzocaine has been researched along with Disease Models, Animal in 6 studies
Benzocaine: A surface anesthetic that acts by preventing transmission of impulses along NERVE FIBERS and at NERVE ENDINGS.
dextran sulfate sodium : An organic sodium salt of dextran sulfate. It induces colitis in mice.
benzocaine : A benzoate ester having 4-aminobenzoic acid as the acid component and ethanol as the alcohol component. A surface anaesthetic, it is used to suppress the gag reflex, and as a lubricant and topical anaesthetic on the larynx, mouth, nasal cavity, respiratory tract, oesophagus, rectum, urinary tract, and vagina.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Human prion diseases are fatal neurodegenerative disorders that include sporadic, infectious and genetic forms." | 1.62 | An in vivo Caenorhabditis elegans model for therapeutic research in human prion diseases. ( Beaudry, P; Bizat, N; Brandel, JP; Gougerot, A; Haïk, S; Laoues, S; Laplanche, JL; Levavasseur, E; Normant, S; Parrales, V; Privat, N; Ravassard, P; Roussel, J, 2021) |
| "A dose-dependent toxic effect of Auralgan was noted on cultured cells." | 1.42 | Assessment of ototoxicity of intratympanic administration of Auralgan in a chinchilla animal model. ( Bezdjian, A; Daniel, SJ; Mujica-Mota, MA; Salehi, P; Schermbrucker, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Bizat, N | 1 |
| Parrales, V | 1 |
| Laoues, S | 1 |
| Normant, S | 1 |
| Levavasseur, E | 1 |
| Roussel, J | 1 |
| Privat, N | 1 |
| Gougerot, A | 1 |
| Ravassard, P | 1 |
| Beaudry, P | 1 |
| Brandel, JP | 1 |
| Laplanche, JL | 1 |
| Haïk, S | 1 |
| Mujica-Mota, MA | 1 |
| Bezdjian, A | 1 |
| Salehi, P | 1 |
| Schermbrucker, J | 1 |
| Daniel, SJ | 1 |
| Cereda, CM | 1 |
| Guilherme, VA | 1 |
| Alkschbirs, MI | 1 |
| de Brito Junior, RB | 1 |
| Tofoli, GR | 1 |
| Franz-Montan, M | 1 |
| de Araujo, DR | 1 |
| de Paula, E | 1 |
| Mitchell, VA | 1 |
| White, DM | 1 |
| Cousins, MJ | 1 |
| Demetrescu, M | 1 |
| Julien, RM | 1 |
6 other studies available for benzocaine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
An in vivo Caenorhabditis elegans model for therapeutic research in human prion diseases.
Topics: Animals; Animals, Genetically Modified; Benzocaine; Brain; Caenorhabditis elegans; Caenorhabditis el | 2021 |
Assessment of ototoxicity of intratympanic administration of Auralgan in a chinchilla animal model.
Topics: Animals; Antipyrine; Auditory Threshold; Benzocaine; Cells, Cultured; Chinchilla; Disease Models, An | 2015 |
Liposomal butamben gel formulations: toxicity assays and topical anesthesia in an animal model.
Topics: 3T3 Cells; Administration, Topical; Anesthesia, Local; Animals; Benzocaine; Cell Survival; Cells, Cu | 2017 |
The long-term effect of epidural administration of butamben suspension on nerve injury-induced allodynia in rats.
Topics: Analgesia, Epidural; Anesthetics, Local; Animals; Benzocaine; Disease Models, Animal; Locomotion; Lo | 1999 |
Local anesthesia and experimental epilepsy.
Topics: Animals; Benzocaine; Cats; Disease Models, Animal; Female; Lidocaine; Male; Procaine; Seizures; Time | 1974 |